CompletedNot Applicable

Yttrium-90 (Y90) Glass Microspheres PET/CT in Imaging Patients With Liver Tumors

United States42 participantsStarted 2017-02-15

Plain-language summary

This clinical trial studies how well yttrium-90 (Y90) glass microspheres positron emission tomography (PET)/computed tomography (CT) works in imaging patients with liver tumors . Images produced by PET/CT may provide better information about the distribution of particles, such as Y90 glass microspheres, delivered for selective internal radiation therapy (SIRT) as compared to regular medical care images useing technetium Tc-99m albumin-aggregated single photon emission computed tomography (SPECT)/CT images.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patient provides written informed consent * Patient is referred for 90Y SIRT radioembolization of liver tumor(s) * Patient is capable of complying with study procedures * Patient is able to remain still for duration of imaging procedure (approximately 30 minutes total for digital PET/CT) Exclusion Criteria: * Patient is pregnant or nursing

What they're measuring

Image Quality for 90-Y PET/CT Scans

Timeframe: 1 day

Trial details

NCT IDNCT03109262

SponsorStanford University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2019-05-30

Results submitted2021-08-12

View on ClinicalTrials.gov More Primary Malignant Liver Neoplasm trials